2018
DOI: 10.1136/ebmed-2017-110845
|View full text |Cite
|
Sign up to set email alerts
|

When is a guideline not a guideline? The devil is in the details

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
15
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 32 publications
1
15
0
Order By: Relevance
“…Meehl (), Grove, Zald, Lebow, Snitz, and Nelson (), and Kahneman and Klein () argued that algorithms could do as least as well as a psychiatrist in the treatment of mental illness, and the development of algorithms for treatment is an active area of ongoing research (see Adli et al ()). On the other hand, Frank and Zeckhauser () expressed concern that guidelines could prevent doctors from providing care that is sufficiently individualized, while Cosgrove, Shaughnessy, and Shaneyfelt () worried that guidelines may be influenced by pharmaceutical companies. More generally, management practices have been shown to be strongly related to outcomes in health care settings, and the question of how best to structure guidelines for doctors is an important one (see Bloom, Propper, Seiler, and Van Reenen () and Tsai, Jha, Gawande, Huckman, Bloom, and Sadun ()).…”
Section: Background: Previous Work On Doctor Decision Making and Pracmentioning
confidence: 99%
“…Meehl (), Grove, Zald, Lebow, Snitz, and Nelson (), and Kahneman and Klein () argued that algorithms could do as least as well as a psychiatrist in the treatment of mental illness, and the development of algorithms for treatment is an active area of ongoing research (see Adli et al ()). On the other hand, Frank and Zeckhauser () expressed concern that guidelines could prevent doctors from providing care that is sufficiently individualized, while Cosgrove, Shaughnessy, and Shaneyfelt () worried that guidelines may be influenced by pharmaceutical companies. More generally, management practices have been shown to be strongly related to outcomes in health care settings, and the question of how best to structure guidelines for doctors is an important one (see Bloom, Propper, Seiler, and Van Reenen () and Tsai, Jha, Gawande, Huckman, Bloom, and Sadun ()).…”
Section: Background: Previous Work On Doctor Decision Making and Pracmentioning
confidence: 99%
“…Both studies were published in the psychiatric journal Neuropsychiatric Disease and Treatment , whose editor is described as an ‘independent pharma consultant [who] advises and consults worldwide to several pharmaceutical and venture capital organizations’. The unsubstantiated positive characterisation of this digital medication is a public health issue because this is the scientific literature that will guide prescribing practices and policy initiatives, and will likely be used to inform the development of new treatment guidelines 41…”
Section: Discussionmentioning
confidence: 99%
“…Meehl (1954), Grove et al (2000) and Kahneman and Klein (2009) argue that algorithms could do as least as well as a psychiatrist in the treatment of mental illness, and the development of algorithms for treatment is an active area of ongoing research (see Adli et al (2017)). On the other hand, Frank and Zeckhauser (2007) express concern that guidelines could prevent doctors from providing care that is sufficiently individualized, while Cosgrove et al (2018) worry that guidelines may be influenced by pharmaceutical companies. More generally, management practices have been shown to be strongly related to outcomes in health care settings, and the question of how best to structure guidelines for doctors is an important one (see Bloom et al (2015) and Tsai et al (2015)).…”
Section: Stylementioning
confidence: 99%